Dark Forest Capital Management’s Ginkgo Bioworks DNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-1,675
Closed -$89.1K 1125
2023
Q1
$89.1K Buy
+1,675
New +$106K 0.02% 698

Other funds holding DNA

Dark Forest Capital Management's DNA Position: Q2 2023 in Review

Dark Forest Capital Management sold out of Ginkgo Bioworks (DNA) in Q2 2023, closing a stake of 1,675 shares — an estimated $89.1K sold.

Dark Forest Capital Management first reported a position in DNA in Q1 2023 and held it in 1 quarter. The position peaked at $89.1K in Q1 2023. 315 funds tracked by Wall St. Rank hold DNA as of Q2 2023.

  • Dark Forest Capital Management reported no remaining Ginkgo Bioworks position as of Q2 2023 after selling out during the quarter.
  • Dark Forest Capital Management sold 1,675 Ginkgo Bioworks shares in Q2 2023, an estimated $89.1K.
  • Dark Forest Capital Management first reported a position in Ginkgo Bioworks in Q1 2023 and held it in 1 quarter.
  • Dark Forest Capital Management's Ginkgo Bioworks position peaked at $89.1K in Q1 2023.
  • 315 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2023.

Based on Dark Forest Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.